• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿根廷HIV-1感染患者中HLA-B*57:01等位基因的流行率

Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.

作者信息

Moragas M, Belloso W H, Baquedano M S, Gutierrez M I, Bissio E, Larriba J M, Fay F, Aulicino P, Gurevich J M, Yaunguzian M F, Maldonado A C, Falistocco C, Sen L, Mangano A

机构信息

Laboratorio de Biología Celular y Retrovirus-CONICET, Hospital de Pediatría 'Prof. Dr Juan P. Garrahan', Buenos Aires, Argentina.

Instituto de Ciencias Básicas y Medicina Experimental, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

出版信息

Tissue Antigens. 2015 Jul;86(1):28-31. doi: 10.1111/tan.12575. Epub 2015 Apr 29.

DOI:10.1111/tan.12575
PMID:25922880
Abstract

Hypersensitivity reaction to abacavir (ABC hypersensitivity syndrome, AHS) is strongly associated with the presence of the HLA-B57:01 allele. This study was designed to estimate the prevalence of HLA-B57:01 allele in Argentinean HIV-1 infected patients. We analyzed the presence of HLA-B57:01 allele in 1646 HIV-1 infected patients from different regions of Argentina. This allele was detected in 81 patients; most of them corresponded to patients living in the central region of the country. The prevalence of HLA-B57:01 was 4.9%, similar to other Caucasian populations and higher than other data reported for South American populations. This strongly supports screening for the presence of HLA-B*57:01 in abacavir treatment of HIV-1 in our country.

摘要

对阿巴卡韦的超敏反应(阿巴卡韦超敏综合征,AHS)与HLA - B57:01等位基因的存在密切相关。本研究旨在评估阿根廷HIV - 1感染患者中HLA - B57:01等位基因的流行率。我们分析了来自阿根廷不同地区的1646例HIV - 1感染患者中HLA - B57:01等位基因的存在情况。在81例患者中检测到该等位基因;其中大多数是居住在该国中部地区的患者。HLA - B57:01的流行率为4.9%,与其他白种人群相似,高于报道的南美人群的其他数据。这有力地支持了在我国对HIV - 1患者进行阿巴卡韦治疗时筛查HLA - B*57:01的存在情况。

相似文献

1
Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.阿根廷HIV-1感染患者中HLA-B*57:01等位基因的流行率
Tissue Antigens. 2015 Jul;86(1):28-31. doi: 10.1111/tan.12575. Epub 2015 Apr 29.
2
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.北美HIV感染受试者中HLA - B*57:01等位基因的流行率以及等位基因检测对HLA - B*57:01阴性受试者中阿巴卡韦相关超敏反应发生率的影响。
BMC Infect Dis. 2017 Apr 11;17(1):256. doi: 10.1186/s12879-017-2331-y.
3
The frequency of HLA-B(∗)57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica.哥斯达黎加多数人群中HLA - B(∗)57:01的频率及阿巴卡韦超敏反应风险
Hum Immunol. 2014 Nov;75(11):1092-6. doi: 10.1016/j.humimm.2014.09.011. Epub 2014 Oct 5.
4
Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan.台湾地区HIV感染患者中阿巴卡韦超敏反应的发生率及其与HLA-B*5701的关系。
J Antimicrob Chemother. 2007 Sep;60(3):599-604. doi: 10.1093/jac/dkm243. Epub 2007 Jul 12.
5
HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.进行HLA - B*5701筛查以检测对阿巴卡韦超敏反应的易感性。
J Antimicrob Chemother. 2007 Apr;59(4):591-3. doi: 10.1093/jac/dkl557. Epub 2007 Feb 22.
6
HLA-B*5701 screening for hypersensitivity to abacavir.进行HLA-B*5701筛查以检测对阿巴卡韦的超敏反应。
N Engl J Med. 2008 Feb 7;358(6):568-79. doi: 10.1056/NEJMoa0706135.
7
Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.在一大群感染艾滋病毒的患者中,阿巴卡韦不良反应与HLA - B*57:01单倍型的相关性。
Pharmacogenet Genomics. 2020 Oct;30(8):167-174. doi: 10.1097/FPC.0000000000000409.
8
Successful implementation of a national HLA-B*5701 genetic testing service in Canada.在加拿大成功实施全国性HLA - B*5701基因检测服务。
Tissue Antigens. 2010 Jan;75(1):12-8. doi: 10.1111/j.1399-0039.2009.01383.x. Epub 2009 Oct 15.
9
Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.关于阿巴卡韦诱导的过敏反应研究:药物遗传学向个体化医学转化的成功范例。
Sci China Life Sci. 2013 Feb;56(2):119-24. doi: 10.1007/s11427-013-4438-8. Epub 2013 Feb 8.
10
HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.HIV感染的印度儿童中的HLA - B*5701等位基因及其与阿巴卡韦超敏反应的关联
Indian Pediatr. 2018 Feb 15;55(2):140-141. Epub 2017 Dec 14.

引用本文的文献

1
Distribution of CCR5-Δ32 and HLA-B*57:01 alleles in HIV-seropositive and HIV-exposed seronegative Peruvian individuals.CCR5-Δ32和HLA-B*57:01等位基因在秘鲁HIV血清阳性和暴露于HIV但血清阴性个体中的分布。
Hum Genome Var. 2025 Aug 26;12(1):15. doi: 10.1038/s41439-025-00321-3.
2
Pharmacogenetics of HIV therapy: State of the art in Latin American countries.艾滋病治疗的药物遗传学:拉丁美洲国家的最新状况
Genet Mol Biol. 2022 Sep 30;45(3 Suppl 1):e20220120. doi: 10.1590/1678-4685-GMB-2022-0120. eCollection 2022.
3
Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions.
药物不良反应药物基因组学的数据库与生物信息学方法综述
Pharmgenomics Pers Med. 2021 Jan 13;14:61-75. doi: 10.2147/PGPM.S290781. eCollection 2021.
4
HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia.哥伦比亚初治 HIV 感染患者中 HLA-B*57:01 等位基因的流行率。
BMC Infect Dis. 2019 Sep 9;19(1):793. doi: 10.1186/s12879-019-4415-3.